File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Phase I trial design for drug combinations with Bayesian model averaging

TitlePhase I trial design for drug combinations with Bayesian model averaging
Authors
Jin, IHHuo, LYin, GYuan, Y
KeywordsBayesian adaptive design
Bayesian model averaging
drug combinations
maximum tolerated dose
phase I trial
toxicity
Issue Date2015
PublisherJohn Wiley & Sons, Ltd. The Journal's web site is located at http://www.interscience.wiley.com/jpages/1539-1604/
Citation
Pharmaceutical Statistics, 2015, v. 14, p. 108-119 How to Cite?
DOI: http://dx.doi.org/10.1002/pst.1668
Persistent Identifierhttp://hdl.handle.net/10722/217219
ISI Accession Number ID
WOS:000351527100005

 

DC FieldValueLanguage
dc.contributor.authorJin, IH-
dc.contributor.authorHuo, L-
dc.contributor.authorYin, G-
dc.contributor.authorYuan, Y-
dc.date.accessioned2015-09-18T05:52:36Z-
dc.date.available2015-09-18T05:52:36Z-
dc.date.issued2015-
dc.identifier.citationPharmaceutical Statistics, 2015, v. 14, p. 108-119-
dc.identifier.urihttp://hdl.handle.net/10722/217219-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Ltd. The Journal's web site is located at http://www.interscience.wiley.com/jpages/1539-1604/-
dc.relation.ispartofPharmaceutical Statistics-
dc.subjectBayesian adaptive design-
dc.subjectBayesian model averaging-
dc.subjectdrug combinations-
dc.subjectmaximum tolerated dose-
dc.subjectphase I trial-
dc.subjecttoxicity-
dc.titlePhase I trial design for drug combinations with Bayesian model averaging-
dc.typeArticle-
dc.identifier.emailYin, G: gyin@hku.hk-
dc.identifier.authorityYin, G=rp00831-
dc.identifier.doi10.1002/pst.1668-
dc.identifier.scopuseid_2-s2.0-84925625817-
dc.identifier.hkuros251609-
dc.identifier.volume14-
dc.identifier.spage108-
dc.identifier.epage119-
dc.identifier.isiWOS:000351527100005-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats